Reduced leucocyte zinc in liver disease

Area of Science:

• Biochemistry
• Clinical Medicine
• Nutritional Science

Background:

• Liver disease is associated with various metabolic disturbances.
• Zinc is an essential trace element crucial for numerous cellular functions.
• Previous research has indicated potential alterations in trace element levels in liver disease.

Purpose of the Study:

• To investigate the zinc content in peripheral blood leukocytes of patients with different types of liver disease.
• To compare leukocyte zinc levels with erythrocyte zinc levels in these patients.
• To evaluate the potential of leukocyte zinc as a biomarker for zinc status in liver disease.

Main Methods:

• Measurement of zinc concentration in peripheral blood leukocytes.
• Inclusion of normal controls and patients with primary biliary cirrhosis, alcoholic cirrhosis, and active chronic hepatitis.
• Comparison of zinc levels between different patient groups and controls.

Main Results:

• A significant reduction in leukocyte zinc was observed in patients with primary biliary cirrhosis, alcoholic cirrhosis, and active chronic hepatitis compared to normal controls.
• No significant reduction in erythrocyte zinc levels was found in the same patient groups.
• This indicates a specific depletion of zinc in nucleated blood cells.

Conclusions:

• Patients with certain liver diseases exhibit zinc deficiency in nucleated tissues, specifically leukocytes.
• Leukocyte zinc levels may serve as a valuable indicator for assessing the zinc status in patients with liver disease.
• Further research is warranted to explore the clinical implications of leukocyte zinc deficiency in liver disease management.